You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 9,914,738


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,914,738 protect, and when does it expire?

Patent 9,914,738 protects BYFAVO and is included in one NDA.

This patent has thirty-two patent family members in nineteen countries.

Summary for Patent: 9,914,738
Title:Short-acting benzodiazepine salts and their polymorphic forms
Abstract: The invention relates to besylate salts of the compound of formula (I): ##STR00001## Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
Inventor(s): Tilbrook; Gary Stuart (Huntington, GB), Quegan; Louisa Jane (Cambridge, GB)
Assignee: PAION UK LIMITED (Cambridge Cambridgeshire, GB)
Application Number:15/703,945
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Device; Dosage form;

Drugs Protected by US Patent 9,914,738

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acacia BYFAVO remimazolam besylate POWDER;INTRAVENOUS 212295-001 Oct 6, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,914,738

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0613692.3Jul 10, 2006
United Kingdom0613694.9Jul 10, 2006

International Family Members for US Patent 9,914,738

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E480532 ⤷  Sign Up
Australia 2007274054 ⤷  Sign Up
Brazil PI0714886 ⤷  Sign Up
Canada 2657347 ⤷  Sign Up
China 101501019 ⤷  Sign Up
China 103288834 ⤷  Sign Up
China 104059071 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.